Genetically determined high activity of IL-12 and IL-18 in ulcerative colitis and TLR5 in Crohns disease were associated with non-response to anti-TNF therapy

Steffen Bank,Paal Skytt Andersen,Johan Burisch,Natalia Pedersen,Stine Roug,J Galsgaard,Stine Ydegaard Turino,Jacob Broder Brodersen,Shaista Rashid,Britt Kaiser Rasmussen,Sara Avlund,Thomas Bastholm Olesen,Hans Jürgen Hoffmann,Bjørn A. Nexø,Jacob Sode,Ulla Vogel,Vibeke Andersen

Genetically determined high activity of IL-12 and IL-18 in ulcerative colitis and TLR5 in Crohns disease were associated with non-response to anti-TNF therapy

2018

Steffen Bank
Paal Skytt Andersen
Johan Burisch
Natalia Pedersen
Stine Roug
J Galsgaard
Stine Ydegaard Turino
Jacob Broder Brodersen
Shaista Rashid
Britt Kaiser Rasmussen
Sara Avlund
Thomas Bastholm Olesen
Hans Jürgen Hoffmann
Bjørn A. Nexø
Jacob Sode
Ulla Vogel
Vibeke Andersen

Genetically determined high activity of IL-12 and IL-18 in ulcerative colitis and TLR5 in Crohns disease were associated with non-response to anti-TNF therapy

Keywords:

Interleukin 18
Pharmacology
Functional genomics
Drug development
Biology
Ulcerative colitis
Disease
TLR5
Interleukin 12
Proteomics
Interferon gamma
Candidate gene
TBX21
Single-nucleotide polymorphism

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations